Krieg, who comes to HCC from the University Research Priority Program (
URPP) in Zurich, Switzerland, wanted to know if the technology could be used to predict which patients might respond to certain treatments.
This work was funded by the University of Zurich Forschungskredit (credit number: 57113401) and the University of Zurich University Research Priority Program (
URPP) Systems Biology/Functional Genomics, a Grant from the Swiss National Science Foundation (31003A_141222, UFG), and the Swiss SystemsX.ch initiative project InfectX (UFG).